Albrecht G R, Cavallini B, Davidson I
Laboratoire de Génétique Moléculaire des Eucaryotes du CNRS, Unité 184 de Biologie Moléculaire et de Génie Génétique de l'INSERM, Faculté de Médecine, Strasbourg, France.
Nucleic Acids Res. 1989 Oct 11;17(19):7945-63. doi: 10.1093/nar/17.19.7945.
The interactions in vivo between cellular proteins and the Simian Virus (SV40) early promoter region, contained in a plasmid capable of replicating in Cos cells, have been characterized by DNaseI and dimethyl sulfate (DMS) footprinting. The relative contribution of each GC-motif within the 21 bp repeat upstream element to transcription was first determined after transfection of Cos cells with either the wild type 21 bp repeats or recombinants where the GC-motifs were mutated either individually or in neighboring pairs. Mutation of GC-motifs III and VI was the most detrimental, mutation of GC-I, -IV and -V also decreased promoter activity but to a lesser extent, while mutation of GC-II had little effect on transcription. All six GC-motifs of the wild type 21 bp repeats were found protected from DNaseI nuclease attack in vivo though to varying degrees. Motifs GC-III, -V and -VI were more strongly protected than GC-I, -II and -IV. In vivo DNaseI footprinting of recombinants bearing mutations in the GC-motifs demonstrated the specificity of factor interaction and further indicated that, in agreement with the previously published in vitro results, the binding of factor(s) to each of the GC-motifs was independent. DMS protection experiments identified specific guanine (G) contacts characteristic of Sp1 binding to the GC-motifs and this in vivo pattern was compared to that obtained in vitro using a crude nuclear extract. These results indicate that the transcription factor Sp1 interacts in vivo with the GC-motifs of the SV40 early promoter.
利用DNA酶I和硫酸二甲酯(DMS)足迹法,对细胞蛋白与猿猴病毒(SV40)早期启动子区域在体内的相互作用进行了表征。该启动子区域包含在一个能够在Cos细胞中复制的质粒中。在用野生型21 bp重复序列或GC基序单独或成对突变的重组体转染Cos细胞后,首先确定了21 bp重复上游元件中每个GC基序对转录的相对贡献。GC基序III和VI的突变最为有害,GC-I、-IV和-V的突变也会降低启动子活性,但程度较小,而GC-II的突变对转录影响不大。野生型21 bp重复序列的所有六个GC基序在体内均受到保护,免受DNA酶I核酸酶的攻击,尽管程度不同。基序GC-III、-V和-VI的保护作用比GC-I、-II和-IV更强。对GC基序中带有突变的重组体进行体内DNA酶I足迹分析,证明了因子相互作用的特异性,并进一步表明,与先前发表的体外结果一致,因子与每个GC基序的结合是独立的。DMS保护实验确定了Sp1与GC基序结合所特有的特定鸟嘌呤(G)接触点,并将这种体内模式与使用粗核提取物在体外获得的模式进行了比较。这些结果表明,转录因子Sp1在体内与SV40早期启动子的GC基序相互作用。